Bibliography of Medication Compliance

s from conference/smposium/workshop ....................................................................14 Newsletters, editorials, commentaries, special reports..........................................................15 Websites ......................................................................................................................................15 Others...........................................................................................................................................15 Contact us ....................................................................................................................................16 Bibliography of Medication Compliance. Page 3 Peer-reviewed papers 1. Arthritis/osteoporosis/musculoskeletal disorders De Klerk E, van der Linden SJ. Compliance monitoring of NSAID drug therapy in ankylosing spondylitis, experiences with an electronic monitoring device. Br J Rheumatol 1996; 35(1):60-65. 2. Cancer Khalil AA, Bentzen SM, Bernier J, Saunders MI, Horiot JC, Van Den BW et al. Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Int J Radiat Oncol Biol Phys 2003; 55(3):568-575. Foucar K, Duncan MH, Stidley CA, Wiggins CL, Hunt WC, Key CR. Survival of children and adolescents with acute lymphoid leukemia. A study of American Indians and Hispanic and non-Hispanic whites treated in New Mexico (1969 to 1986). Cancer 1991; 67(8):2125-2130. Phipps S, DeCuir-Walley S. Adherence issues in pediatric bone marrow transplantation. J Ped Pshychol 1990; 15:459-475. Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol 1990; 8(2):356-364. Dekker AW, Rozenberg-Arska M, Verhoef J. Infection prophylaxis in acute leukemia: A comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Ann Intern Med 1987; 160:7-12. Pizzo PA, Robichaud KJ, Edwards BK, Schumaker C, Kramer BS, Johnson A. Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial. J Pediatr 1983; 102(1):125133. 3. Cardiovascular diseases/disorders (including smoking, obesity & stroke) Ongtengco I, Morales D, Sanderson J, Lu ZR, Beilin LJ, Burke V et al. Persistence of the antihypertensive efficacy of amlodipine and nifedipine GITS after two 'missed doses': a randomised, double-blind comparative trial in Asian patients. J Hum Hypertens 2002; 16(11):805-813. Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart 2002; 88(3):229-233. Nuesch R, Schroeder K, Dieterle T, Martina B, Battegay E. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. BMJ 2001; 323(7305):142-146. Dew MA, Kormos RL, Roth LH, Murali S, DiMartini A, Griffith BP. Early post-transplant medical Bibliography of Medication Compliance. Page 4 compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant 1999; 18(6):549-562. Irvine J, Baker B, Smith J, Jandciu S, Paquette M, Cairns J et al. Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Psychosom Med 1999; 61(4):566-575. De Geest S, Abraham I, Moons P, Vandeputte M, Van Cleemput J, Evers G et al. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplant 1998; 17(9):854-863. Mounier-Vehier C, Bernaud C, Carre A, Lequeuche B, Hotton JM, Charpentier JC. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release. Am J Hypertens 1998; 11(4 Pt 1):478-486. McCrindle BW, O'Neill MB, Cullen-Dean G, Helden E. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. J Pediatr 1997; 130(2):266-273. Morrell RW, Park DC, Kidder DP, Martin M. Adherence to antihypertensive medications across the life span. Gerontologist 1997; 37(5):609-619. van der Meer FJ, Briet E, Vandenbroucke JP, Sramek DI, Versluijs MH, Rosendaal FR. The role of compliance as a cause of instability in oral anticoagulant therapy. Br J Haematol 1997; 98(4):893-900. Rich MW, Gray DB, Beckham V, Wittenberg C, Luther P. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 1996; 101(3):270-276. Schectman G, Hiatt J. Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals. Am J Med 1996; 100(2):197-204. Jacobson TA, Chin MM, Curry CL, Miller V, Papademetriou V, Schlant RC et al. Efficacy and safety of pravastatin in African Americans with primary hypercholesterolemia. Arch Intern Med 1995; 155(17):1900-1906. Glynn RJ, Buring JE, Manson JE, LaMotte F, Hennekens CH. Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study. Arch Intern Med 1994; 154(23):2649-2657. Gallagher EJ, Viscoli CM, Horwitz RI. The relationship of treatment adherence to the risk of death after myocardial infarction in women. Journal of the American Medical Association 1993; 270(6):742-744. Schectman G, Hiatt J, Hartz A. Evaluation of the effectiveness of lipid-lowering therapy (bile acid sequestrants, niacin, psyllium, and lovastatin) for treating hypercholesterolemia in veterans. Am J Cardiol 1993; 71:759-765. Horwitz RI, Viscoli CM, Berkman L, Donaldson RM, Horwitz SM, Murray CJ et al. Treatment adherence Bibliography of Medication Compliance. Page 5 and risk of death after a myocardial infarction. Lancet 1990; 336(8714):542-545. Reis GJ, Boucher TM, Sipperly ME, Silverman DI, McCabe CH, Baim DS et al. Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet 1989; 2(8656):177-181. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24:67-74. Hoeg JM, Maher MB, Bou E, Zech LA, Bailey KR, Gregg RE et al. Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin. Circulation 1984; 70(6):1004-1011. Widmer RB, Cadoret RJ, Troughton E. Compliance characteristics of 291 hypertensive patients from a rural midwest area. J Fam Pract 1983; 17(4):619-625. 4. Diabetes/metabolic disorder 5. Eye & skin diseases/disorders Kass MA, Gordon M, Meltzer DW. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Opthalmol 1986; 101:524-530. Granstrom PA. Progression of visual field defects in glaucoma. Relation to compliance with pilocarpine therapy. Arch Ophthalmol 1985; 103(4):529-531. 6. Infection Guaraldi G, Murri R, Orlando G, Orlandi E, Sterrantino G, Borderi M et al. Morphologic Alterations in HIV-Infected People with Lipodystrophy Are Associated with Good Adherence to HAART. HIV Clin Trials 2003; 4(2):99-106. Samman Y, Krayem A, Haidar M, Mimesh S, Osoba A, Al Mowaallad A et al. Treatment outcome of tuberculosis among Saudi nationals: role of drug resistance and compliance. Clin Microbiol Infect 2003; 9(4):289-294. Ammassari A, Antinori A, Cozzi-Lepri A, Trotta MP, Nasti G, Ridolfo AL et al. Relationship between HAART adherence and adipose tissue alterations. J Acquir Immune Defic Syndr 2002; 31 Suppl 3:S1404.:S140-S144. Cohn SE, Kammann E, Williams P, Currier JS, Chesney MA. Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency Bibliography of Medication Compliance. Page 6 Syndrome. Clin Infect Dis 2002; 34(8):1129-1136. Flandre P, Peytavin G, Meiffredy V, Saidi Y, Descamps D, Delagnes M et al. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial. Antivir Ther 2002; 7(2):113-121. Garcia dO, Knobel H, Carmona A, Guelar A, Lopez-Colomes JL, Cayla JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr 2002; 30(1):105-110. Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV et al. Intermittent use of triplecombination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS 2002; 16(7):1051-1058. Howard AA, Arnsten JH, Lo Y, Vlahov D, Rich JD, Schuman P et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS 2002; 16(16):2175-2182. Ickovics JR, Cameron A, Zackin R, Bassett R, Chesney M, Johnson VA et al. Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370. Antivir Ther 2002; 7(3):185-193. Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis 2002; 34(8):1115-1121. McHutchison JG, Manns M, Patel K, Poynard T, Lindsay KL, Trepo C et al. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 2002; 123(4):1061-1069. Raboud JM, Harris M, Rae S, Montaner JS. Impact of adherence on duration of virological suppression among patients receiving combination antiretroviral therapy. HIV Med 2002; 3(2):118-124. Van Vaerenbergh K, De Geest S, Derdelinckx I, Bobbaers H, Carbonez A, Deschamps A et al. A combination of poor adherence and a low baseline susceptibility score is highly predictive for HAART failure. Antivir Chem Chemother 2002; 13(4):231-240. Brigido LF, Rodrigues R, Casseb J, Oliveira D, Rossetti M, Menezes P et al. Impact of adherence to antiretroviral therapy in HIV-1-infected patients at a university public service in Brazil. AIDS Patient Care STDS 2001; 15(11):587-593. DeMasi RA, Graham NM, Tolson JM, Pham SV, Capuano GA, Fisher RL et al. Correlation between selfreported adherence to highly active antiretroviral therapy (HAART) and virologic outcome. Adv Ther 2001; 18(4):163-173. Gross R, Bilker WB, Friedman HM, Strom BL. Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS 2001; 15(16):2109-2117. Bibliography of Medication Compliance. Page 7 McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clin Infect Dis 2001; 33(5):700-705. Nieuwkerk PT, Sprangers MA, Burger DM, Hoetelmans RM, Hugen PW, Danner SA et al. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med 2001; 161(16):1962-1968. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000; 14(4):357-366. Giron-Gonzalez JA, Lopez-Sanchez A, Elvira J, Perez E, Fernandez-Gutierrez C. Effect of patient adherence to antiretroviral therapy on CD4+ cell count, HIV-1 RNA, and serum concentrations of tumor necrosis factor and its soluble receptors. Eur J Clin Microbiol Infect Dis 2000; 19(11):852-858. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133(1):21-30. Bachmann LH, Stephens J, Richey CM, Hook EW, III. Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance. Sex Transm Dis 1999; 26(5):272-278. Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, Beall GN et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS 1999; 13(9):1099-1107. Maher K, Klimas N, Fletcher MA, Cohen V, Maggio CM, Triplett J et al. Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an Urban Veterans Affairs Medical Center. J Acquir Immune Defic Syndr 1999; 22(4):358-363. d'Arminio MA, Testa L, Adorni F, Chiesa E, Bini T, Moscatelli GC et al. Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection. AIDS 1998; 12(13):1631-1637. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest 1997; 111(5):1168-1173. Anastasio GD, Little JM, Jr., Robinson MD, Pettice YL, Leitch BB, Norton HJ. Impact of compliance and side effects on the clinical outcome of patients treated with oral erythromycin. Pharmacotherapy 1994; 14(2):229-234. Browning GG, Gatehouse S, Calder IT. Medical management of active chronic otitis media: A controlled study. J Laryngol Otol 1988; 102:491-495. Bibliography of Medication Compliance. Page 8 Macknin ML, Jones PK. Oral dexamethasone for treatment of persistent middle ear effusion. Pediatrics 1985; 75:329-335. Reed BD, Lutz LJ, Zazove P, Ratcliffe SD. Compliance with acute otitis media treatment. J Fam Pract 1984; 19(5):627-632. Schwartz RH, Puglise J, Rodriguez WJ. Sulphamethoxazole prophylaxis in the otitis-prone child. Arch Dis Child 1982; 57:590-593. 7. Gastrointestinal diseases/disorders Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003; 114(1):39-43. Wermeille J, Cunningham M, Dederding JP, Girard L, Baumann R, Zelger G et al. Failure of Helicobacter pylori eradication: is poor compliance the main cause? Gastroenterol Clin Biol 2002; 26(3):216-219. Breuer RI, Soergel KH, Lashner BA, Christ ML, Hanauer SB, Vanagunas A et al. Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut 1997; 40(4):485491. Dohil R, Israel DM, Hassall E. Effective 2-week therapy for Helicobacter pylori disease in children. Am J Gastroenterol 1997; 92:244-247. Cutler AF, Schubert TT. Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol 1993; 88:505-509. Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ, Jr., Klein PD et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102(2):493-496. Rappaport L, Landman G, Fenton T, Levine MD. Locus of control as predictor of compliance and outcome in treatment of encopresis. J Pediatr 1986; 109(6):1061-1064. 8. Mental health Hunt GE, Bergen J, Bashir M. Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophr Res 2002; 54(3):253-264. Scott J, Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am J Psychiatry 2002; 159(11):1927-1929. Demyttenaere K, Mesters P, Boulanger B, Dewe W, Delsemme MH, Gregoire J et al. Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine. J Affect Disord 2001; Bibliography of Medication Compliance. Page 9 65(3):243-252. Thompson C, Peveler RC, Stephenson D, McKendrick J. Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: A randomized comparison of fluoxetine and a tricyclic antidepressant. American Journal of Psychiatry 2000; 157(3):338-343. Verdoux H, Lengronne J, Liraud F, Gonzales B, Assens F, Abalan F et al. Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects. Acta Psychiatr Scand 2000; 102(3):203-210. Verghese A, John JK, Rajkumar S, Richard J, Sethi BB, Trivedi JK. Factors associated with the course and outcome of schizophrenia in India. Results of a two-year multicentre follow-up study. Br J Psychiatry 1989; 154:499-503.:499-503. Connelly CE, Davenport YB, Nurnberger JI, Jr. Adherence to treatment regimen in a lithium carbonate clinic. Arch Gen Psychiatry 1982; 39(5):585-588. 9. Neurological diseases/disorders & pain Lutz RW, Silbret M, Olshan N. Treatment outcome and compliance with therapeutic regimens: long-term follow-up of a multidisciplinary pain program. Pain 1983; 17(3):301-308. 10. Other diseases/disorders Billups SJ, Malone DC, Carter BL. The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 2000; 20(8):941-949. Hays RD, Kravitz RL, Mazel RM, Sherbourne CD, DiMatteo MR, Rogers WH et al. The impact of patient adherence on health outcomes for patients with chronic disease in the Medical Outcomes Study. J Behav Med 1994; 17(4):347-360. Wright DD, Franks PJ, Blair SD, Backhouse CM, Moffatt C, McCollum CN. Oxerutins in the prevention of recurrence in chronic venous ulceration: randomized controlled trial. Br J Surg 1991; 78(10):1269-1270. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Noncompliance in organ transplant recipients. Transplantation 1990; 49(2):374-377. 11. Respiratory diseases/disorders Dasgupta R, Guest JF. Factors Affecting UK Primary-Care Costs of Managing Patients with Asthma over 5 Years. Pharmacoeconomics 2003; 21(5):357-369. Soussan D, Liard R, Zureik M, Touron D, Rogeaux Y, Neukirch F. Treatment compliance, passive Bibliography of Medication Compliance. Page 10 smoking, and asthma control: a three year cohort study. Arch Dis Child 2003; 88(3):229-233. Balkrishnan R, Christensen DB. Inhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary disease. Clin Ther 2000; 22(4):452-469. Jonasson G, Carlsen KH, Sodal A, Jonasson C, Mowinckel P. Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma. Eur Respir J 1999; 14(1):150-154. van Ganse E, Hubloue I, Vincken W, Leufkens HG, Gregoire J, Ernst P. Actual use of inhaled corticosteroids and risk of hospitalisation: a case-control study. Eur J Clin Pharmacol 1997; 51(6):449-454. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98(6 Pt 1):1051-1057. 12. Urinary & kidney diseases/disorders De Geest S, Borgermans L, Gemoets H, Abraham I, Vlaminck H, Evers G et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995; 59(3):340-347. Hilbrands LB, Hoitsma AJ, Koene RAP. Medication compliance after renal transplantation. Transplantation 1995; 60:914-920. 13. Women's & Men's health Review articles 1. Arthritis/osteoporosis/musculoskeletal disorders No articles identified. 2. Cancer Urquhart J. Patient compliance with crucial drug regimens: implications for prostate cancer. Eur Urol 1996;29 Suppl 2:124-31. 3. Cardiovascular diseases/disorders (including smoking, obesity & stroke) Bibliography of Medication Compliance. Page 11 Cramer JA. Effect of partial compliance on cardiovascular medication effectiveness. Heart. 2002 Aug;88(2):203-6. Girvin B, Johnston GD. The implications of noncompliance with antihypertensive medication. Drugs. 1996 Aug;52(2):186-95. McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes. A critical review. Arch Intern Med. 1997 Sep 22;157(17):1921-9. Rudd P. Clinicians and patients with hypertension: unsettled issues about compliance. Am Heart J 1995;130:572-9. Rudd P. Partial compliance: implications for clinical practice. J Cardiovasc Pharmacol. 1993;22 Suppl A:S1-5. Urquhart J. Partial compliance in cardiovascular disease: risk implications. Br J Clin Pract Suppl. 1994 May;73:2-12. Williams GH. Assessing patient wellness: new perspectives on quality of life and compliance. Am J Hypertens. 1998 Nov;11(11 Pt 2):186S-191S. 4. Diabetes/metabolic disorder No articles identified. 5. Eye & skin diseases/disorders No articles identified. 6. Infection Miller LG, Hays RD. Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications. AIDS Read 2000;10(3):177-85. Perno CF, Ceccherini-Silberstein F, De Luca A, Cozzi-Lepri A, Gori C, Cingolani A, Bellocchi MC, Trotta MP, Piano P, Forbici F, Scasso A, Vullo V, d'Arminio Monforte A, Antinori A; AdICoNA Study Group. Virologic correlates of adherence to antiretroviral medications and therapeutic failure. J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S118-22. Press N, Tyndall MW, Wood E, Hogg RS, Montaner JS. Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S112-7. 7. Gastrointestinal diseases/disorders Kane S. Patient compliance and outcomes. Inflamm Bowel Dis. 1999 May;5(2):134-7. Bibliography of Medication Compliance. Page 12 8. Mental health Demyttenaere K, Haddad P. Compliance with antidepressant therapy and antidepressant discontinuation symptoms. Acta Psychiatr Scand Suppl. 2000;403:50-6. 9. Neurological diseases/disorders & pain Garnett WR. Antiepileptic drug treatment: outcomes and adherence. Pharmacotherapy. 2000 Aug;20(8 Pt 2):191S-199S. Pledger GW. Compliance in clinical trials: impact on design, analysis and interpretation. Epilepsy Res Suppl. 1988;1:125-33. Turk DC, Rudy TE. Neglected topics in the treatment of chronic pain patients--relapse, noncompliance, and adherence enhancement. Pain. 1991 Jan;44(1):5-28. 10. Other diseases/disorders – includes reviews of all conditions/multiple conditions/general health Epstein LH. The direct effects of compliance on health outcome. Health Psychol 1984;3(4):385-93. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med. 1993 Aug 23;153(16):1863-8. Kardas P. [Patient non-compliance as a cause of treatment failure]. Pol Merkuriusz Lek. 2000 Oct;9(52):732-5. Article in Polish. Matsui DM. Drug compliance in pediatrics. Clinical and research issues. Pediatr Clin North Am. 1997 Feb;44(1):1-14. Urquhart J. Erratic patient compliance with prescribed drug regimens: target for drug delivery systems. Clin Pharmacol Ther. 2000 Apr;67(4):331-4. 11. Respiratory diseases/disorders Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients: is there a solution to the problem? Ann Allergy Asthma Immunol. 1997 Sep;79(3):177-85. Ramsey SD. Suboptimal medical therapy in COPD: exploring the causes and consequences. Chest. 2000 Feb;117(2 Suppl):33S-7S. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med 1994;149(2 Pt 2):S69-76; discussion S77-8. 12. Urinary & kidney diseases/disorders Bibliography of Medication Compliance. Page 13 Leaderbach-Hofmann K, Bunzel B. Noncompliance in organ transplant recipients: a literature review. Gen Hosp Psychiatry 2000; 22: 412-24. 13. Women's & Men's health No articles identified.